1. Home
  2. NUWE vs GOODO Comparison

NUWE vs GOODO Comparison

Compare NUWE & GOODO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NUWE
  • GOODO
  • Stock Information
  • Founded
  • NUWE 1999
  • GOODO N/A
  • Country
  • NUWE United States
  • GOODO United States
  • Employees
  • NUWE N/A
  • GOODO 72
  • Industry
  • NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • GOODO Real Estate
  • Sector
  • NUWE Health Care
  • GOODO Real Estate
  • Exchange
  • NUWE Nasdaq
  • GOODO Nasdaq
  • Market Cap
  • NUWE 3.9M
  • GOODO N/A
  • IPO Year
  • NUWE N/A
  • GOODO N/A
  • Fundamental
  • Price
  • NUWE $0.93
  • GOODO $20.08
  • Analyst Decision
  • NUWE Strong Buy
  • GOODO
  • Analyst Count
  • NUWE 1
  • GOODO 0
  • Target Price
  • NUWE $17.00
  • GOODO N/A
  • AVG Volume (30 Days)
  • NUWE 70.0K
  • GOODO N/A
  • Earning Date
  • NUWE 05-06-2025
  • GOODO N/A
  • Dividend Yield
  • NUWE N/A
  • GOODO N/A
  • EPS Growth
  • NUWE N/A
  • GOODO N/A
  • EPS
  • NUWE N/A
  • GOODO N/A
  • Revenue
  • NUWE $8,740,000.00
  • GOODO N/A
  • Revenue This Year
  • NUWE $22.96
  • GOODO N/A
  • Revenue Next Year
  • NUWE $29.97
  • GOODO N/A
  • P/E Ratio
  • NUWE N/A
  • GOODO N/A
  • Revenue Growth
  • NUWE N/A
  • GOODO N/A
  • 52 Week Low
  • NUWE $0.75
  • GOODO N/A
  • 52 Week High
  • NUWE $12.60
  • GOODO N/A
  • Technical
  • Relative Strength Index (RSI)
  • NUWE 48.62
  • GOODO 51.50
  • Support Level
  • NUWE $0.87
  • GOODO $19.61
  • Resistance Level
  • NUWE $0.95
  • GOODO $20.11
  • Average True Range (ATR)
  • NUWE 0.09
  • GOODO 0.50
  • MACD
  • NUWE 0.02
  • GOODO 0.10
  • Stochastic Oscillator
  • NUWE 64.37
  • GOODO 87.20

About NUWE Nuwellis Inc.

Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.

About GOODO Gladstone Commercial Corporation 6.00% Series G Cumulative Redeemable Preferred Stock par value $0.001 per share

Gladstone Commercial Corp is a real estate investment trust, which engages in investing and owning net leased industrial, commercial, and retail real property and making long-term industrial and commercial mortgage loans. Its portfolio consists of single-tenant commercial, industrial real properties, and medical properties nationwide. Its principal investment objectives are to generate income from rental properties.

Share on Social Networks: